Product image of Kardatuxan (Rivaroxaban) supplied by GNH India

Kardatuxan

Active Ingredient:
Rivaroxaban
Origin:
EU

Kardatuxan (Rivaroxaban)

Rivaroxaban, the active ingredient in Kardatuxan, is a direct factor Xa inhibitor presented as an oral tablet for oral use. It is indicated for the prevention of stroke and systemic embolism in patients with non‑valvular atrial fibrillation and for the treatment and secondary prevention of deep vein thrombosis and pulmonary embolism in adult patients under medical supervision as prescribed by a healthcare professional.

GNH India supplies Kardatuxan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kardatuxan (rivaroxaban) is used in the anticoagulation pathway to reduce thrombus formation.

  • Non‑valvular atrial fibrillation: reduces risk of stroke and systemic embolism.
  • Deep vein thrombosis: treats acute clot and prevents recurrence.
  • Pulmonary embolism: facilitates clot resolution and lowers recurrence risk.
  • Secondary prevention of venous thromboembolism: maintains anticoagulation after initial treatment.

How It Works

  • Rivaroxaban selectively inhibits the active site of coagulation factor Xa, blocking the conversion of prothrombin to thrombin. By reducing thrombin generation, it diminishes fibrin clot formation without requiring antithrombin activation, providing a predictable anticoagulant effect across a wide therapeutic range.

Side Effects

Common Side Effects

  • Minor bleeding (e.g., gum or nosebleeds).
  • Bruising at sites of minor trauma.
  • Gastrointestinal discomfort or dyspepsia.
  • Headache.
  • Dizziness.

Serious or Rare Side Effects

  • Major hemorrhage (intracranial, gastrointestinal, or fatal bleeding).
  • Spinal or epidural hematoma, especially after neuraxial procedures.
  • Hepatic injury with elevated transaminases.
  • Severe allergic reactions such as anaphylaxis.

Precautions & Warnings

Before initiating therapy, evaluate patient-specific risk factors and monitor appropriately.

  • Renal function assessment: adjust use in severe impairment.
  • Bleeding risk evaluation: avoid in active bleeding conditions.
  • Concomitant antiplatelet therapy: assess increased bleeding potential.
  • Surgery or invasive procedures: discontinue as recommended prior to the procedure.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Rivaroxaban may interact with several medicines that affect hemostasis or drug metabolism.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma concentrations.
  • Other anticoagulants (e.g., warfarin, heparin): additive bleeding risk.
  • Antiplatelet agents (e.g., clopidogrel, aspirin): heightened bleeding potential.

Moderate Interactions (Monitor Closely)

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): may raise exposure.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase gastrointestinal bleeding risk.
  • Selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline): potential for enhanced bleeding.

Frequently Asked Questions

Kardatuxan contains rivaroxaban and is prescribed to prevent stroke and systemic embolism in patients with non‑valvular atrial fibrillation, as well as to treat and reduce recurrence of deep vein thrombosis and pulmonary embolism.

Rivaroxaban selectively blocks factor Xa, a key enzyme in the coagulation cascade. By inhibiting factor Xa, it prevents the conversion of prothrombin to thrombin, thereby reducing the formation of fibrin clots.

The dose of Kardatuxan is individualized by the prescribing clinician based on the specific indication, renal function, and patient characteristics. Patients should follow the dosage instructions provided by their healthcare professional.

Safety data for rivaroxaban in pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Kardatuxan, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with warfarin, rivaroxaban offers a predictable anticoagulant effect without routine INR monitoring and has fewer food and drug interactions. Relative to other direct oral anticoagulants such as apixaban, dosing frequency and renal clearance considerations differ, so clinicians choose based on patient profile and therapeutic goals.

Kardatuxan tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Kardatuxan is taken orally with a full glass of water. It can be swallowed with or without food, unless the prescribing information advises otherwise. Patients should not split, crush, or chew the tablets unless specifically instructed.

The most serious risks involve bleeding complications, including intracranial hemorrhage, gastrointestinal bleeding, and spinal or epidural hematoma. Patients should be educated to recognize signs of major bleeding and seek immediate medical attention if they occur.

Kardatuxan is contraindicated in individuals with active major bleeding, severe hepatic disease associated with coagulopathy, and those who have a known hypersensitivity to rivaroxaban or any of its excipients. Caution is also advised for patients with uncontrolled hypertension or recent major surgery.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Rivaroxaban

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT